MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-CH-01-0010044
Novosys Life Sciences Private Limited - pharma in Dhanas, Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹29.92 Cr
▲ 255% YoY
Net profit · FY 2025
₹74.79 Lakh
Net margin 2.5%
EBITDA · FY 2025
₹1.44 Cr
EBITDA margin 4.8%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹14.58 Cr
Satisfied ₹2 Cr
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
About Novosys Life Sciences Private Limited
Data last updated:
Novosys Life Sciences Private Limited is a private limited company based in Dhanas, Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U85200CH2019PTC042388. Its GSTIN is 04AAGCN4185N1Z2 (Chandigarh).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Dayawanti and Kiran Bala.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No. 4 2nd Floor Star Tower Above Pnb Bank, Dhanas, Chandigarh, India – 160014.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.92 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹74.79 Lakh (net margin 2.5%) and EBITDA of ₹1.44 Cr (EBITDA margin 4.8%). Revenue has grown at a compounded annual rate (CAGR) of 95% over three years and 90% over five years.
As per MCA filings, the company has open charges of ₹14.58 Cr and satisfied charges of ₹2 Cr on record. Court records list 3 cases involving the company, including 3 filed against it; 3 cases are pending.
Novosys Life Sciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-CH-01-0010044). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website novosyslifesciences.com.
Company details
CIN U85200CH2019PTC042388
Registration Number 042388
Incorporation Date 19 February 2019
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-CH-01-0010044
Recognitions & Rankings of Novosys Life Sciences
Contact details
Novosys Life Sciences Private Limited's registered office is in Dhanas, Chandigarh. Its website is novosyslifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No. 4 2nd Floor Star Tower Above Pnb Bank, Dhanas, Chandigarh, India – 160014
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Novosys Life Sciences Private Limited, buy the company report.
Comprehensive company report
Novosys Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Novosys Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Novosys Life Sciences Private Limited, buy the company report.
Financials of Novosys Life Sciences Private Limited
FY 2024 filings availableNovosys Life Sciences Private Limited reported revenue of ₹29.92 Cr (up 255% YoY) for FY 2025.
Revenue · FY 2025
₹29.92 Cr ▲ 255%
Net profit · FY 2025
₹74.79 Lakh margin 2.5%
EBITDA · FY 2025
₹1.44 Cr margin 4.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 255%
3 years · compounded
▲ 95%
5 years · compounded
▲ 90%
EBITDA CAGR growth
1 year
▲ 396%
3 years · compounded
▲ 153%
5 years · compounded
▲ 130%
Revenue has grown at a compounded annual rate (CAGR) of 90% over five years, including 255% growth in the latest year. EBITDA rose 396% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.44 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹74.79 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.8% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novosys Life Sciences Private Limited, buy the company report.
Board of directors of Novosys Life Sciences Private Limited
Novosys Life Sciences has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dayawanti | Director | 19 Feb 2019 | 7 Years 8 Months | Current |
| Kiran Bala | Director | 19 Feb 2019 | 7 Years 8 Months | Current |
| Sanjeev Mittal | Additional Director | 14 Oct 2025 | 1 Years 0 Months | Current |
Auditor
Novosys Life Sciences Private Limited is audited by Akhil Jindal & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Akhil Jindal & Associates | FY 2023 | 033034N |
Shareholding
The shareholding of Novosys Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Novosys Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹14.58 Cr
Satisfied charges
₹2 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 May 2025 | 101113612 | Others | ₹7.5 Lakh | Open | |
| 04 Jun 2024 | 100935165 | Hdfc Bank Limited | ₹14.5 Cr | Open | |
| 30 Oct 2023 | 100840104 | Others | ₹2 Cr | Satisfied |
To see the full charge records of Novosys Life Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Novosys Life Sciences Private Limited has 3 court cases on record: 3 filed against it. All cases are pending.
Total cases
3
Filed against the company
3
Pending
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 3 | 3 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed against the company by Novartis Ag & Anr. | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Novartis Ag & Anr. | Pending |
To see the full case history of Novosys Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Novosys Life Sciences Private Limited has 1 MSME Form 1 return on record for the period ending Sep 2020, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Mascot Health Series Private Limited. |
To see the full MSME payment records of Novosys Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Novosys Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAGCN4185N1Z2 | Chandigarh | Active | 04 Jul 2019 |
To see the full GST registrations and return filing status of Novosys Life Sciences Private Limited, buy the company report.
Recent activity
Novosys Life Sciences Private Limited has 5 board changes on record since 2019: 4 appointments and 1 cessation. The latest: Sanjeev Mittal was appointed as Additional Director on 14 Oct 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 1,450.00 Lakh registered on 04 Jun 2024 with Charge ID 100935165 was modified on 18 Nov 2025.
Appointed
Sanjeev Mittal was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 7.50 Lakh with Charge ID 101113612 was registered on 06 May 2025.
AGM
Novosys Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 30 Oct 2023 via Charge ID 100840104 with Others was fully satisfied on 13 Jun 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,450.00 Lakh with Charge ID 100935165 was registered on 04 Jun 2024.
Filing
Novosys Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 100840104 was registered on 30 Oct 2023.
Ceased
Balbir Singh Negi ceased to be Director.
Appointed
Balbir Singh Negi was appointed as Director.
Appointed
Dayawanti was appointed as Director.
Appointed
Kiran Bala was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Novosys Life Sciences is an active private limited company based in Dhanas, Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 February 2019 (7+ years old) and is registered under CIN U85200CH2019PTC042388.
Novosys Life Sciences has 3 current directors:
- Dayawanti - Director
- Kiran Bala - Director
- Sanjeev Mittal - Additional Director
The latest financial statements of Novosys Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Novosys Life Sciences is 04AAGCN4185N1Z2, registered in Chandigarh.
The CIN (Corporate Identification Number) of Novosys Life Sciences is U85200CH2019PTC042388. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novosys Life Sciences has 3 court cases on record: 3 filed against it. 3 are pending.
Novosys Life Sciences was incorporated on 19 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chandigarh.
Sanjeev Mittal was appointed as Additional Director on 14 Oct 2025. Balbir Singh Negi ceased to be Director on 30 Jul 2019. Balbir Singh Negi was appointed as Director on 19 Feb 2019. Novosys Life Sciences has 5 board changes on record in total.
Yes, Novosys Life Sciences is registered as an MSME under Udyam registration (number: UDYAM-CH-01-0010044).
Novosys Life Sciences has 1 MSME Form 1 return on record for the period ending Sep 2020, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 31 Oct 2020.
Novosys Life Sciences can be reached through the website novosyslifesciences.com. Its registered office is in Dhanas, Chandigarh, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages